PROTHENA CORPORATION PUBLIC LIMITED COMPANY Financing Cash Flow
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Financing Cash Flow of -$22.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$15.57M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$6.95M.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$17.00K, a 105.11% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for fiscal 2025 was -$139.00K, a 108.94% decline from fiscal 2024.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for fiscal 2024 was $1.55M, a 96.55% decline from fiscal 2023.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for fiscal 2023 was $45.10M, a 81.32% decline from fiscal 2022.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY net cash provided by (used in) financing activities for fiscal 2022 was $241.46M, a 26.86% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$22.51M 10-Q · filed 2026-08-06 | -$22.51M derived: sum of 3 quarters · filed 2026-08-06 | -$22.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$6.95M 10-Q · filed 2026-05-07 | -$6.95M derived: sum of 2 quarters · filed 2026-05-07 | -$6.96M derived: sum of 3 quarters · filed 2026-05-07 | -$7.04M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$17.00K derived: sum of 2 quarters · filed 2026-02-27 | -$91.00K derived: sum of 3 quarters · filed 2026-08-06 | -$139.00K 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$91.00K derived: sum of 2 quarters · filed 2026-08-06 | -$139.00K 10-Q · filed 2025-11-06 | -$198.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$122.00K 10-Q · filed 2026-08-06 | -$181.00K derived: sum of 3 quarters · filed 2026-08-06 | $152.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$48.00K 10-Q · filed 2026-05-07 | -$107.00K derived: sum of 2 quarters · filed 2026-05-07 | $226.00K derived: sum of 3 quarters · filed 2026-05-07 | $670.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $274.00K derived: sum of 2 quarters · filed 2026-02-27 | $718.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.55M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $777.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.61M 10-Q · filed 2025-11-06 | $2.10M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $444.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $1.28M 10-Q · filed 2025-08-04 | $1.76M derived: sum of 3 quarters · filed 2026-02-27 | $4.47M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $836.00K 10-Q · filed 2025-05-08 | $1.32M derived: sum of 2 quarters · filed 2026-02-27 | $4.03M derived: sum of 3 quarters · filed 2026-02-27 | $22.66M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.19M derived: sum of 2 quarters · filed 2026-02-27 | $21.82M derived: sum of 3 quarters · filed 2026-02-27 | $45.10M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $21.34M derived: sum of 2 quarters · filed 2024-11-12 | $44.62M 10-Q · filed 2024-11-12 | $265.38M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $18.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $41.91M 10-Q · filed 2024-08-08 | $262.67M derived: sum of 3 quarters · filed 2025-02-27 | $280.80M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $23.28M 10-Q · filed 2024-05-08 | $244.05M derived: sum of 2 quarters · filed 2025-02-27 | $262.18M derived: sum of 3 quarters · filed 2025-02-27 | $263.40M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $220.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $238.90M derived: sum of 2 quarters · filed 2025-02-27 | $240.12M derived: sum of 3 quarters · filed 2025-02-27 | $241.46M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $18.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $19.36M derived: sum of 2 quarters · filed 2023-11-02 | $20.69M 10-Q · filed 2023-11-02 | $22.46M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.56M 10-Q · filed 2023-08-03 | $4.33M derived: sum of 3 quarters · filed 2024-02-22 | $91.35M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $1.34M 10-Q · filed 2023-05-04 | $3.11M derived: sum of 2 quarters · filed 2024-02-22 | $90.12M derived: sum of 3 quarters · filed 2024-02-22 | $110.34M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $88.79M derived: sum of 2 quarters · filed 2024-02-22 | $109.00M derived: sum of 3 quarters · filed 2024-02-22 | $190.33M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $87.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $107.23M derived: sum of 2 quarters · filed 2022-11-03 | $188.56M 10-Q · filed 2022-11-03 | $188.56M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $20.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $101.55M 10-Q · filed 2022-08-08 | $101.55M derived: sum of 3 quarters · filed 2023-02-28 | $101.61M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $81.33M 10-Q · filed 2022-05-05 | $81.33M derived: sum of 2 quarters · filed 2023-02-28 | $81.39M derived: sum of 3 quarters · filed 2023-02-28 | $81.39M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $64.00K derived: sum of 2 quarters · filed 2023-02-28 | $64.00K derived: sum of 3 quarters · filed 2023-02-28 | $215.00K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $64.00K derived: sum of 2 quarters · filed 2021-11-04 | $215.00K 10-Q · filed 2021-11-04 | $228.00K derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $151.00K 10-Q · filed 2021-08-05 | $164.00K derived: sum of 3 quarters · filed 2022-02-25 | $164.00K derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $151.00K 10-Q · filed 2021-05-11 | $164.00K derived: sum of 2 quarters · filed 2022-02-25 | $164.00K derived: sum of 3 quarters · filed 2022-02-25 | $374.00K derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $13.00K derived: sum of 2 quarters · filed 2022-02-25 | $223.00K derived: sum of 3 quarters · filed 2022-02-25 | $228.00K 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $210.00K derived: sum of 2 quarters · filed 2020-11-04 | $215.00K 10-Q · filed 2020-11-04 | -$1.09M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $215.00K 10-Q · filed 2020-08-06 | -$1.09M derived: sum of 3 quarters · filed 2021-02-26 | -$2.06M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-06 | -$1.30M derived: sum of 2 quarters · filed 2021-02-26 | -$2.27M derived: sum of 3 quarters · filed 2021-02-26 | -$3.13M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$2.28M derived: sum of 2 quarters · filed 2021-02-26 | -$3.14M derived: sum of 3 quarters · filed 2021-02-26 | $40.04M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$975.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$1.84M derived: sum of 2 quarters · filed 2019-11-05 | $41.35M 10-Q · filed 2019-11-05 | $42.81M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | -$861.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $42.32M 10-Q · filed 2019-08-06 | $43.78M derived: sum of 3 quarters · filed 2020-03-03 | $46.39M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | $43.18M 10-Q · filed 2019-05-07 | $44.64M derived: sum of 2 quarters · filed 2020-03-03 | $47.25M derived: sum of 3 quarters · filed 2020-03-03 | $48.72M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2017-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $4.07M derived: sum of 2 quarters · filed 2020-03-03 | $5.53M derived: sum of 3 quarters · filed 2020-03-03 | $165.40M 10-K · filed 2020-03-03 | ||||
| 2017-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.07M derived: sum of 2 quarters · filed 2018-11-06 | $163.94M 10-Q · filed 2018-11-06 | $183.24M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $161.33M 10-Q · filed 2018-08-07 | $180.64M derived: sum of 3 quarters · filed 2019-03-15 | $184.88M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $159.87M 10-Q · filed 2018-05-09 | $179.17M derived: sum of 2 quarters · filed 2019-03-15 | $183.41M derived: sum of 3 quarters · filed 2019-03-15 | $184.19M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $19.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $23.54M derived: sum of 2 quarters · filed 2019-03-15 | $24.33M derived: sum of 3 quarters · filed 2019-03-15 | $153.29M 10-K · filed 2019-03-15 | $154.31M 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.02M derived: sum of 2 quarters · filed 2017-11-07 | $133.99M 10-Q · filed 2017-11-07 | $134.81M 10-Q · filed 2016-11-02 | $133.58M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-06-30 | $782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $129.74M 10-Q · filed 2017-08-09 | $130.04M 10-Q · filed 2016-08-02 | $129.34M derived: sum of 3 quarters · filed 2018-02-26 | $131.99M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-03-31 | $128.96M 10-Q · filed 2017-05-09 | $129.06M 10-Q · filed 2016-05-04 | $128.56M derived: sum of 2 quarters · filed 2018-02-26 | $131.21M derived: sum of 3 quarters · filed 2018-02-26 | $264.92M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | -$405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.25M derived: sum of 2 quarters · filed 2018-02-26 | $135.96M derived: sum of 3 quarters · filed 2018-02-26 | $136.99M 10-K · filed 2018-02-26 | $140.84M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $136.37M derived: sum of 2 quarters · filed 2016-11-02 | $137.39M 10-Q · filed 2016-11-02 | $137.38M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $133.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $134.74M 10-Q · filed 2016-08-02 | $134.73M derived: sum of 3 quarters · filed 2017-02-27 | $149.40M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $1.03M 10-Q · filed 2016-05-04 | $1.01M derived: sum of 2 quarters · filed 2017-02-27 | $15.69M derived: sum of 3 quarters · filed 2017-02-27 | $118.60M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $14.66M derived: sum of 2 quarters · filed 2017-02-27 | $117.58M derived: sum of 3 quarters · filed 2017-02-27 | $118.08M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $14.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $117.59M derived: sum of 2 quarters · filed 2015-11-02 | $118.09M 10-Q · filed 2015-11-02 | $202.75M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | $102.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $103.42M 10-Q · filed 2015-08-05 | $188.07M derived: sum of 3 quarters · filed 2016-02-25 | $187.96M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $507.00K 10-Q · filed 2015-05-06 | $85.16M derived: sum of 2 quarters · filed 2016-02-25 | $85.04M derived: sum of 3 quarters · filed 2016-02-25 | $85.04M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $84.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $84.53M derived: sum of 2 quarters · filed 2016-02-25 | $84.53M derived: sum of 3 quarters · filed 2016-02-25 | $84.45M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | -$117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$117.00K derived: sum of 2 quarters · filed 2014-11-04 | -$201.00K 10-Q · filed 2014-11-04 | $141.32M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$84.00K 10-Q · filed 2014-08-05 | $141.44M derived: sum of 3 quarters · filed 2015-03-13 | $148.99M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | -$84.00K 10-Q · filed 2014-05-05 | $141.44M derived: sum of 2 quarters · filed 2015-03-13 | $148.99M derived: sum of 3 quarters · filed 2015-03-13 | $159.39M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $141.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $149.07M derived: sum of 2 quarters · filed 2015-03-13 | $159.47M derived: sum of 3 quarters · filed 2015-03-13 | $168.23M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $7.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $17.95M derived: sum of 2 quarters · filed 2013-11-12 | $26.71M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | $10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $19.16M 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | $8.76M 10-Q · filed 2013-05-15 | |||||||
| 2011-12-31 | $20.29M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |